AU5533300A - Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia - Google Patents

Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia

Info

Publication number
AU5533300A
AU5533300A AU55333/00A AU5533300A AU5533300A AU 5533300 A AU5533300 A AU 5533300A AU 55333/00 A AU55333/00 A AU 55333/00A AU 5533300 A AU5533300 A AU 5533300A AU 5533300 A AU5533300 A AU 5533300A
Authority
AU
Australia
Prior art keywords
oxodihydrooxadiazinylphenyl
amides
novel
treating anemia
anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55333/00A
Inventor
Martin Bechem
Gabriele Braunlich
Burkhard Fugmann
Christian Gerdes
Michael Logers
Klemens Lustig
Ulrich Dr Nielsch
Carsten Schmeck
Michael Sperzel
Jurgen Stoltefuss
Werner Sturmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU5533300A publication Critical patent/AU5533300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55333/00A 1999-06-29 2000-06-16 Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia Abandoned AU5533300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19929787 1999-06-29
DE19929787A DE19929787A1 (en) 1999-06-29 1999-06-29 New 4- (2-oxodihydrooxadiazinylphenyl) amides and their use
PCT/EP2000/005570 WO2001000601A1 (en) 1999-06-29 2000-06-16 Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia

Publications (1)

Publication Number Publication Date
AU5533300A true AU5533300A (en) 2001-01-31

Family

ID=7912944

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55333/00A Abandoned AU5533300A (en) 1999-06-29 2000-06-16 Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia

Country Status (3)

Country Link
AU (1) AU5533300A (en)
DE (1) DE19929787A1 (en)
WO (1) WO2001000601A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10010425A1 (en) * 2000-03-03 2001-09-06 Bayer Ag Medicaments for treating anemia, containing new or known 6-(4-(acylamino)-phenyl)-5-methyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
DE10111842A1 (en) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Antithrombotic carboxylic acid amides, their preparation and their use as pharmaceuticals
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
EP1852443A1 (en) 2006-05-05 2007-11-07 Leukocare AG Biocompatible three dimensional matrix for the immobilization of biological substances
JP7120549B2 (en) * 2016-12-15 2022-08-17 小野薬品工業株式会社 Activator of TREK (TWIK-associated K channel) channels
JOP20200024A1 (en) * 2017-08-04 2020-02-02 Bayer Ag Dihydrooxadiazinones
CA3071795A1 (en) 2017-08-04 2019-02-07 Bayer Aktiengesellschaft 6-phenyl-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5962578A (en) * 1982-10-04 1984-04-10 Mitsui Toatsu Chem Inc Oxadiazine derivative and pharmaceutical composition containing the same
JPH0676325B2 (en) * 1992-05-08 1994-09-28 三井東圧化学株式会社 Antithrombotic agent containing an oxadiazine derivative as an active ingredient
EP0728482A3 (en) * 1995-02-10 1999-10-20 Smithkline Beecham Corporation Use of hcp specific compounds to enhance erythropoiesis
AU6405596A (en) * 1995-06-30 1997-02-05 Smithkline Beecham Corporation Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis
HUP9902086A3 (en) * 1995-12-29 2001-09-28 Smithkline Beecham Corp Thieno[2,3-b]pyrazolo[3,4-d]pyridin-3-ones, their use, pharmaceutical compositions containing them, process for their preparation, intermediates

Also Published As

Publication number Publication date
DE19929787A1 (en) 2001-01-04
WO2001000601A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
PL349781A1 (en) Novel sulfonamide compounds and uses thereof
ZA200107870B (en) Fused-ring compounds and use thereof.
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
HUP0203746A3 (en) Novel composition and method for stabilizing the same
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AU1403501A (en) Novel composition and use
AU4117000A (en) Cosmetic product and its use
EP1147213A4 (en) Novel rgs-containing molecules and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU5533300A (en) Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia
AU3541097A (en) Substituted n-(5-isothiazolyl) thioamides
AUPP989499A0 (en) Treated closures 3
HK1044947A1 (en) Benzamide derivatives and drugs containing the same
AUPP989299A0 (en) Treated closures 1
AU5569200A (en) Uracil compounds and use thereof
AUPP989399A0 (en) Treated closures 2
AU2207001A (en) Novel compounds and process
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU1986097A (en) Pyridylmethyl nitriles, amides and thioamides useful as fungicides
AU5979300A (en) Angiopoietin-6 and uses thereof
AU4506499A (en) Novel 2,4-diaminophenol derivatives and the use thereof
AU5815400A (en) N-[4-(6-oxotetrahydrotriazinyl)phenyl]amides and use thereof
AU5014700A (en) Novel integrin alphasubunit and uses thereof
AU6875800A (en) Heterocyclic compounds and process for the preparation thereof
AU9646998A (en) Heterocyclic compounds and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase